Olaplex (NASDAQ:OLPX) Earns Market Perform Rating from Telsey Advisory Group

Telsey Advisory Group restated their market perform rating on shares of Olaplex (NASDAQ:OLPXFree Report) in a research report released on Friday morning, Benzinga reports. They currently have a $2.00 target price on the stock.

A number of other equities research analysts have also recently commented on the company. Truist Financial lowered their target price on Olaplex from $7.00 to $3.00 and set a buy rating on the stock in a research note on Monday, March 4th. Piper Sandler upgraded Olaplex from an underweight rating to a neutral rating and lifted their target price for the stock from $1.25 to $2.00 in a research note on Tuesday, March 19th. Seven analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Olaplex has an average rating of Hold and an average target price of $2.59.

View Our Latest Research Report on Olaplex

Olaplex Price Performance

OLPX opened at $1.34 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 10.92 and a quick ratio of 9.21. The company has a market capitalization of $886.22 million, a price-to-earnings ratio of 14.89 and a beta of 2.28. The firm’s fifty day moving average price is $1.73 and its two-hundred day moving average price is $1.97. Olaplex has a 1 year low of $1.19 and a 1 year high of $4.27.

Olaplex (NASDAQ:OLPXGet Free Report) last posted its quarterly earnings data on Thursday, February 29th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.03. The firm had revenue of $111.72 million for the quarter, compared to the consensus estimate of $108.29 million. Olaplex had a net margin of 13.44% and a return on equity of 13.09%. The business’s revenue for the quarter was down 14.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.07 EPS. As a group, analysts anticipate that Olaplex will post 0.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Olaplex

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Waldron Private Wealth LLC increased its position in shares of Olaplex by 62.0% during the fourth quarter. Waldron Private Wealth LLC now owns 16,227 shares of the company’s stock valued at $41,000 after buying an additional 6,213 shares during the period. Quadrant Capital Group LLC boosted its stake in shares of Olaplex by 2,108.4% during the fourth quarter. Quadrant Capital Group LLC now owns 10,048 shares of the company’s stock valued at $26,000 after purchasing an additional 9,593 shares during the period. Quent Capital LLC raised its holdings in shares of Olaplex by 2,463.8% during the fourth quarter. Quent Capital LLC now owns 11,178 shares of the company’s stock valued at $28,000 after acquiring an additional 10,742 shares in the last quarter. Oak Thistle LLC bought a new position in shares of Olaplex during the third quarter valued at approximately $25,000. Finally, Pathstone Family Office LLC raised its holdings in shares of Olaplex by 95.1% during the third quarter. Pathstone Family Office LLC now owns 26,287 shares of the company’s stock valued at $51,000 after acquiring an additional 12,813 shares in the last quarter. 87.37% of the stock is currently owned by institutional investors.

About Olaplex

(Get Free Report)

Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.

Further Reading

Analyst Recommendations for Olaplex (NASDAQ:OLPX)

Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.